Science Corp @science.xyz · 03/10/2026prima.science.xyzPRIMA at EURETINA 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 03/10/2026prima.science.xyzPRIMA at EURETINA 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 03/10/2026Today at EURETINA 2026, the latest PRIMA clinical trial data will be presented during the Industry Symposium “PRIMA Retinal Implant in Geographic Atrophy: Pivotal Trial Evidence and 36-Month Outcomes.” 100
Science Corp @science.xyz · 03/10/2026Heute werden bei der EURETINA 2026 die neuesten Daten aus der PRIMA-Studie im Industriesymposium „PRIMA Retinal Implant in Geographic Atrophy: Pivotal Trial Evidence and 36-Month Outcomes“ vorgestellt. 100
Science Corp @science.xyz · 02/10/2026prima.science.xyzPRIMA at EURETINA 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 02/10/2026Mahi Muqit, MD, PhD, will present the 36-Month outcomes from the PRIMA clinical trial today at EURETINA 2026 in Vienna. See the full list of PRIMA sessions in the link in the comments. 120
Science Corp @science.xyz · 02/10/2026prima.science.xyzPRIMA at EURETINA 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 02/10/2026Mahi Muqit, MD, PhD, stellt heute bei der EURETINA 2026 in Wien die Ergebnisse nach 36 Monaten aus der klinischen Studie zu PRIMA vor. Der Link zu allen PRIMA-Sessions steht im ersten Kommentar. 110
Science Corp @science.xyz · 01/10/2026prima.science.xyzPRIMA at EURETINA 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 01/10/2026EURETINA 2026 begins today in Vienna. Frank Holz, MD, will deliver the keynote lecture "The Dark Side of the Moon: New Horizons in Dry AMD." See the full PRIMA program in the comments. 100
Science Corp @science.xyz · 01/10/2026prima.science.xyzPRIMA at EURETINA 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 01/10/2026Die EURETINA 2026 beginnt heute in Wien. Frank Holz, MD, hält die Keynote „The Dark Side of the Moon: New Horizons in Dry AMD“ Der Link zum vollständigen PRIMA-Programm steht im ersten Kommentar. 110
Science Corp @science.xyz · 30/09/2026prima.science.xyzPRIMA at EURETINA 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 30/09/2026At EURETINA 2026 in Vienna this week, researchers and clinicians behind the PRIMA clinical program will present across nine sessions. See the full PRIMA program in the comments. 100
Science Corp @science.xyz · 30/09/2026prima.science.xyzPRIMA at EURETINA 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 30/09/2026Diese Woche sind Forschende und klinisch tätige Ärzt:innen aus den klinischen Aktivitäten rund um PRIMA bei der EURETINA 2026 in Wien mit Beiträgen in neun Sessions vertreten. Der Link zum vollständigen PRIMA-Programm steht im ersten Kommentar. 101
Science Corp @science.xyz · 28/09/2026primasicht.dePRIMABahnbrechende Technologie zur Wiederherstellung der Sehkraft 000
Science Corp @science.xyz · 28/09/2026Bei der DOG 2026 in Berlin stellte das PRIMA-Team diese Woche in neun Sessions aktuelle Forschungs- und klinische Entwicklungen vor. Danke an die DOG und alle Beteiligten. Mehr über PRIMA: Link in den Kommentaren. 100
Science Corp @science.xyz · 28/09/2026prima.science.xyzPRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 28/09/2026This week at DOG 2026 in Berlin, researchers and clinicians behind the PRIMA clinical program shared the latest research and clinical developments across nine scientific sessions. Thank you to DOG and the physicians, researchers and broader ophthalmology community who joined us this week. 100
Science Corp @science.xyz · 26/09/2026prima.science.xyzPRIMA at DOG 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 26/09/2026Bei der DOG 2026 in Berlin stellen Frank G. Holz, Armin Wolf und Boris Stanzel heute das PRIMA-Netzhautimplantat bei geografischer Atrophie vor. Eine Expertenrunde diskutiert Behandlung und Überweisungswege. Programm: Link in den Kommentaren. 100
Science Corp @science.xyz · 26/09/2026prima.science.xyzPRIMA at DOG 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 26/09/2026Frank G. Holz, MD, Armin Wolf, MD, and Boris Stanzel, MD, PhD, will present “PRIMA Retinal Implant in Geographic Atrophy: From Pivotal Trial Data to the Clinic” today at DOG Deutsche Ophthalmologische Gesellschaft 2026 in Berlin. 100
Science Corp @science.xyz · 26/09/2026prima.science.xyzPRIMA at DOG 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 25/09/2026prima.science.xyz/dog-2026/prima.science.xyzPRIMA at DOG 2026 | PRIMAGroundbreaking Technology for Vision Restoration 000
Science Corp @science.xyz · 25/09/2026primasicht.de/de-de/dog-20...primasicht.dePRIMA auf der DOG 2026 | PRIMABahnbrechende Technologie zur Wiederherstellung der Sehkraft 000
Science Corp @science.xyz · 25/09/2026Lars-Olof Hattenbach, MD, PhD, will deliver the keynote DOG Deutsche Ophthalmologische: “Vision Restoration with the PRIMA Implant: What’s Next?” highlighting results from the PRIMA clinical trial in Berlin. See the full list of PRIMA sessions at DOG 2026 in the link in the comments. 110
Science Corp @science.xyz · 25/09/2026Lars-Olof Hattenbach spricht bei der DOG 2026 in Berlin über die Wiederherstellung des Sehvermögens mit dem PRIMA-Implantat. Klinische Studien zeigen: PRIMA kann bei geografischer Atrophie funktionales zentrales Sehen wiederherstellen. Programm: Link in den Kommentaren. 100
Science Corp @science.xyz · 24/09/2026PRIMA is CE marked in the EU and registered in the UK. It is not FDA-approved and is not commercially available elsewhere. In Australia, PRIMA is an investigational device and is not included in the ARTG. 001
Science Corp @science.xyz · 24/09/2026This is one patient. Help us reach more. Learn if you or a loved one is eligible for PRIMA: patients.science.xyz Join our team: science.xyz/careerspatients.science.xyzPatient Registry | Science CorporationJoin the Science Patient Registry to be considered for participation in our vision loss research studies. 100
Science Corp @science.xyz · 24/09/2026He's now part of the clinical trial testing Science's PRIMA implant (approved in Europe for geographic atrophy) in patients with Stargardt disease and retinitis pigmentosa. During his first rehabilitation session after surgery, he saw a letter again. 100
Science Corp @science.xyz · 24/09/2026Blind Stargardt patient reads letter again in PRIMA by Science clinical trial. Stargardt disease destroys central vision. There is no treatment that brings it back. This clinical trial patient was diagnosed with Stargardt disease and became legally blind – he could no longer read or recognize faces 142
Science Corp @science.xyz · 24/09/202612:30 pm: Lars-Olof Hattenbach, MD, PhD, on “Artificial Vision with a Retinal Chip: New Hope in the Fight Against Blindness” 010
Science Corp @science.xyz · 24/09/202611:18 am: Boris Stanzel, MD, PhD, on “Evaluation of Intraoperative OCT (iOCT) During Subretinal Implantation of the PRIMA Retina Implant” 100
Science Corp @science.xyz · 24/09/202611:09 am: Nicole Eter, MD, PhD, on “Multimodal Retinal Imaging for PRIMA Subretinal Implantation in Patients with Geographic Atrophy” 100
Science Corp @science.xyz · 24/09/202611:09 am: Salvatore Grisanti, MD, PhD, on “Implant Technique for the PRIMA Subretinal Neurostimulation System in Atrophic AMD: Insights, Safety, and Surgical Considerations” 100
Science Corp @science.xyz · 24/09/2026Deutsche Ophthalmologische Gesellschaft 2026 begins today in Berlin with four sessions focused on PRIMA. Today’s program includes: 100
Science Corp @science.xyz · 24/09/2026DOG Deutsche Ophthalmologische Gesellschaft 2026 in Berlin: Heute stehen vier PRIMA-Sessions auf dem Programm. Themen sind Implantation, Netzhautbildgebung, iOCT und künstliches Sehen. Das vollständige Programm: Link in den Kommentaren. 000
Science Corp @science.xyz · 23/09/2026Auf der DOG 2026 präsentieren Forschende und Ärzt:innen der PRIMA-Studie diese Woche in neun Sessions ihre Arbeit. Dazu gehören eine Keynote zur Wiederherstellung des Sehvermögens mit dem PRIMA-Implantat und ein Symposium zur geografischen Atrophie. 000
Science Corp @science.xyz · 21/09/2026prima.science.xyzPRIMA at DOG 2026 | PRIMAGroundbreaking Technology for Vision Restoration 010
Science Corp @science.xyz · 21/09/2026At DOG 2026 this week, researchers and clinicians behind the PRIMA clinical trial will present across nine sessions including a keynote on “Vision Restoration with the PRIMA Implant: What's Next?” and a symposium “PRIMA Retinal Implant in Geographic Atrophy: From Pivotal Trial Data to the Clinic.” 100
Science Corp @science.xyz · 21/09/2026Im Beitrag „Dieser Mann will blinden Menschen das Sehen zurückgeben“ sprach Matthias Hohensee von der Wirtschaftswoche mit Science-CEO Max Hodak über die Technologie hinter PRIMA, die klinischen Studienergebnisse und warum Deutschland zu den ersten Märkten für das Implantatsystem gehört.wiwo.deMedizintechnik: US-Unternehmen bringt Chip für Blinde nach DeutschlandMax Hodak aus den USA hat mit Elon Musk Neuralink gegründet. Nun will er zeigen, dass Gehirntechnologie nicht nur Visionen produziert – sondern etwa auch Blinden helfen kann. 000
Science Corp @science.xyz · 17/09/2026We are excited to announce that our Chief Strategy Officer, Darius Shahida, has been named President. Darius will continue to lead our work with investors, and around global commercialization and partnerships, while helping build the operating infrastructure required for our continued growth.businesswire.com 001
Science Corp @science.xyz · 15/09/20262027 summer intern application will go live early next year. Stay tuned on our careers page:science.xyzOpen Positions | Science CorporationScience Corporation is a clinical-stage medical technology company. 020
Science Corp @science.xyz · 15/09/2026Our 2026 summer interns, in their own words and their own edit. We were lucky to have them! 160
Science Corp @science.xyz · 14/09/2026In a lengthy feature, “This man wants to make it possible for blind people to see again,” Wirtschaftswoche sat down with Science CEO Max Hodak to discuss the PRIMA implant system, its clinical trial results, and why Germany is one of the first markets where patients can access PRIMA.wiwo.deMedizintechnik: US-Unternehmen bringt Chip für Blinde nach DeutschlandMax Hodak aus den USA hat mit Elon Musk Neuralink gegründet. Nun will er zeigen, dass Gehirntechnologie nicht nur Visionen produziert – sondern etwa auch Blinden helfen kann. 010
Science Corp @science.xyz · 12/09/2026Unser neuer Radiospot für PRIMA, unser Netzhautimplantat zur Behandlung der geografischen Atrophie infolge altersbedingter Makuladegeneration, wurde heute während der Bundesliga-Übertragung ausgestrahlt. Hier anhören: 020
Science Corp @science.xyz · 10/09/2026“Just because it’s a big ambitious goal, I don’t think it needs, in the psyche of the popular imagination, to mean it’s unlikely. The original moonshot worked. We did in fact leave a flag on the moon.” – Max Hodak, CEO of Science, in the Financial Times’s new “Moonshot Capitalism” series.ft.comMoonshot capitalism: AI rewrites the venture capital playbookTech investors are rediscovering the kind of long-shot sci-fi bets that helped build Silicon Valley 030
Science Corp @science.xyz · 08/09/2026Frank Brodie, Science's medical director for vision and PRIMA, has been named to The Ophthalmologist's Rising Stars of Retina 2026, which celebrates the ophthalmologists making a sizable impact in the retina space.theophthalmologist.comThe Ophthalmologist | Rising Stars of Retina 2026 010
